key: cord-0738995-7pvrr4j9
authors: Qin, Zhen; Dong, Bin; Wang, Renbing; Huang, Dechun; Wang, Jubo; Feng, Xi; Bian, Jinlei; Li, Zhiyu
title: Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
date: 2021-10-21
journal: Acta Pharm Sin B
DOI: 10.1016/j.apsb.2021.10.011
sha: bdb8506f15a645b65ea9cd93e006d779c522f550
doc_id: 738995
cord_uid: 7pvrr4j9

EIDD-2801 is an orally bioavailable prodrug, which will be applied for emergency use authorization from the U.S. Food and Drug Administration for the treatment of COVID-19. To investigate the optimal parameters, EIDD-2801 was optimized via a four-step synthesis with high purity of 99.9%. The hydroxylamination procedure was telescoped in a one-pot and the final step was precisely controlled on reagents, temperature and reaction time. Compared to the original route, the yield of the new route was enhanced from 17% to 58% without column chromatography. The optimized synthesis has been successfully determinated on a decagram scale: the first step at 200 g and the final step at 20 g. Besides, the relationship between yield and temperature, time, and reagents in the deprotection step was investigated via Shapley value explanation and machine learning approach-decision tree method. The results revealed that reagents have the greatest impact on yield estimation, followed by the temperature.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 has severely impacted public health and economy worldwide 1,2 .

Currently, some promising repurposed drugs have been approved or studied in large clinical trials for COVID-19 patients [3] [4] [5] . EIDD-2801 (1, molnupiravir, MK-4482, Fig.   1 ), an oral prodrug of β-D-N4-hydroxycytidine (2, NHC, EIDD-1931, Fig. 1 ), has proved to be effective against SARS-CoV-2 in clinic trials 6, 7 . It will be applied for emergency use authorization from the U.S. Food and Drug Administration (FDA) by

Merck & Co 6 . It has been demonstrated that 1 has broad-spectrum RNA viruses inhibitory activity by blocking RNA polymerase, especially inhibiting SARS-CoV-2 replication 8, 9 . In 2019, Painter and colleagues 10 from Emory University firstly disclosed a synthesis J o u r n a l P r e -p r o o f of 1 in a 25 g scale (Scheme 1). The starting material uridine was protected with acetone fork, followed by esterification in a one-pot reaction. Then, the chemical intermediate is activated with the 1,2,4-triazole, which is further transformed into hydroxylamine.

After deprotection of the acetone fork, 1 is obtained but no yield has been provided in this step. The low overall yield (not more than 17%) limits the further development.

And the intermediates were purified by column chromatography. These challenges of the above route require a simplified and alternative route with improved yield. Thus, we identify an optimized route to afford 1 with simplified procedures and high yields (58% yield) (Scheme 2). Furthermore, process parameters such as reaction concentration, catalyst loading, and stoichiometry has been optimized. Uridine is selected as starting material, followed by acetone fork protection, O-acylation, hydroxylamination and deprotection. The 2,4,6-triisopropylbenzenesulfonyl chloride is used to sulfonate 4-carbonyl, followed by reaction with hydroxylamine. As machine learning can evaluate and predict the performance and outcome of a synthetic reaction effectively, we also develop a machine learning model to investigate the importance of solvent, temperature, and reaction time with the yield of 1 11, 12 .

J o u r n a l P r e -p r o o f Scheme 2 Improved route to EIDD-2801.

Commercially available uridine was converted to the 2′,3′-O-isopropylidine 3 at room temperature. The synthesis of 3 was started with 1.5 equiv of 2,2-dimethoxypropane and 0.05 equiv of toluene-4-sulfonic acid monohydrate (PTSA•H2O). After solvent removed, crude protection product was dissolved in methyl tert-butyl ether (MTBE) and filtered to remove PTSA. The compound 3 was obtained in 99% yield.

The original route in a patent reported that the compound 3 was acylated using 8.5 equiv of isobutyric anhydride and 0.39 equiv of 4-dimethylaminopyridine (DMAP) 10 .

Owing to the elimination of redundant reagents, a large number of work was increased.

Hence, we investigated the interaction between the equiv of isobutyric anhydride and conversion (Fig. 2) . The 1.0 equiv and 1.1 equiv of isobutyric anhydride gave a poor yield. A 1.5 equiv of isobutyric anhydride provided a complete reaction in a 99% yield of 4. The 2.0 equiv and 8.5 equiv had similar yield to that of 1.5 equiv. It's necessary to remove residual isobutyric anhydride by stirring with petroleum ether to preclude the negative effect of the next step. We also attempted to apply isobutyryl chloride as acylating agent, but it was tended to react with 2-and 4-carbonyl.

J o u r n a l P r e -p r o o f To optimize the reaction condition of deprotection of 5, different reagents, temperature and reaction time were investigated (Supporting Information Table S1).

We found that reaction could proceed smoothly in CF3COOH and PTSA•H2O. The yield of the former could reach 97.6% but the latter could only reach 92.9% (8 h, 28 ℃), which were shown in entry 8 and entry 44. Solvents such as hydrochloric acid gave no conversion at 0 ℃ (entry 16). When increased the temperature (entry 17-24), there were some undetermined impurities. In certain reaction, the product only occupied a small fraction (entry 5 and entry 16). The remaining parts mainly included starting material that was not consumed. Taken purity and operation into consideration, we chose CF3COOH to convert 5. This combination of reagents gave 1 with good reproducibility, J o u r n a l P r e -p r o o f as well as improved yield and purity.

To forecast the final step based on experimental settings, we constructed a machine learning approach-Decision Tree Regressor (DTR) model to study the interaction between yield and temperature, reaction time, and reagents, and to reveal which factor was the most significant in the determination of yield. The motivation of employing DTR was two folds: (1) The best fitted decision tree was shown in Fig. S1 , with each node visualising how decision nodes split up the feature space. The yield of each experiment was depicted as scatters, with their average values displayed as dotted lines. The DTR fits the data well, with the exception of nodes 4 and 10, due to the minimum sample size per node was set to 3 to prevent overfitting. Here, a run from the root node (node 0) down to leaf nodes 3 and 4 was used to explain the decision tree. Starting at the root node, experiments were split by the type of reagents. Experiments with the solvents HCl/MeOH and HCOOH/H2O were placed in node 1, whereas those with CF3COOH/H2O and PTSA·H2O/THF were placed in node 8. The plot on node 0 demonstrates that, on average, when using CF3COOH/H2O and PTSA·H2O/THF as solvent yield over 90%; while, using HCl/MeOH and HCOOH/H2O yield around 60%.

The experiments in node 1 were then further divided by temperature. Experiments with temperatures less than 28 °C inclusive were grouped in node 2, while those with temperatures greater than 50 °C inclusive were grouped in node 5. Consequently, experiments involving an HCl/MeOH or HCOOH/H2O and a temperature less than 28 °C inclusive were classified into node 2. The final decision was determined based on the experiment's duration. If the period was less than 1 h inclusive, the yield would J o u r n a l P r e -p r o o f be 23.07% on average of 8 samples that fell into node 3. If this was not the case, the yield would be 57.84%.

The best fitted Decision Tree Regressor (DTR) to study the relationship between yield and temperature, reaction time, and reagents (the nodes are used to split up the feature space). was used instead of information gain (e.g., Gini or MSE) approach which could also be used to explain feature importance for DTR, due to the gain method was biased to attribute more importance to lower splits. In other words, since trees were constructed greedily, it was expected features near the root of the tree to be more important than features split on near the leaves. This bias potentially leads to inconsistency using the information gain-based method to determine feature importance. For the decision tree in Fig. 3 , feature solvent was applied to divide the tree not just on node 0 but also on node 12, so aggravating the bias. The Shapley importance, on the other hand, reduced this bias because it was mathematically equivalent to average differences in predictions over all possible orderings of the features, rather than just the ordering specified by their position in the tree. 

In summary, an optimized and practical method for the preparation of oral drug EIDD-2801 (1) to treat COVID-19 has been developed. The method from available uridine to EIDD-2801 exhibits easy process with overall yield of 58% and high purity of 99.9%.

A notable improvement is that the hydroxylamination was telescoped in one step, comparing to originally reported two steps in a patent. Furthermore, a problematic 

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

COVID-19: drug targets and potential treatments

Quest for a COVID-19 cure by repurposing small-molecule drugs: mechanism of action, clinical development, synthesis at scale, and outlook for supply

Quest for a cure: potential small-molecule treatments for COVID-19, part 2

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-CoV and naming it SARS-CoV-2

Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia

Study of MK-4482 for prevention of coronavirus disease 2019 (COVID-19) in adults

Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model

Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses

N4-hydroxycytidine and derivatives and antiviral uses related thereto. WO2019113462A1, 13

Predicting reaction performance in C-N cross-coupling using machine learning

Accelerated reactivity mechanism and interpretable machine learning model of n-sulfonylimines toward fast multicomponent reactions

From local explanations to global understanding with explainable AI for trees

We gratefully acknowledge financial support from the National Natural Science 

The authors declare no conflicts of interest.